JAGX Relative Valuation
JAGX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, JAGX is overvalued; if below, it's undervalued.
Historical Valuation
Jaguar Health Inc (JAGX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.16. The fair price of Jaguar Health Inc (JAGX) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：1.10
Fair
-0.12
PE
1Y
3Y
5Y
Trailing
Forward
-8.86
EV/EBITDA
Jaguar Health Inc. (JAGX) has a current EV/EBITDA of -8.86. The 5-year average EV/EBITDA is 2.73. The thresholds are as follows: Strongly Undervalued below -25.35, Undervalued between -25.35 and -11.31, Fairly Valued between 16.78 and -11.31, Overvalued between 16.78 and 30.82, and Strongly Overvalued above 30.82. The current Forward EV/EBITDA of -8.86 falls within the Historic Trend Line -Fairly Valued range.
-1.40
EV/EBIT
Jaguar Health Inc. (JAGX) has a current EV/EBIT of -1.40. The 5-year average EV/EBIT is -2.48. The thresholds are as follows: Strongly Undervalued below -7.47, Undervalued between -7.47 and -4.98, Fairly Valued between 0.02 and -4.98, Overvalued between 0.02 and 2.52, and Strongly Overvalued above 2.52. The current Forward EV/EBIT of -1.40 falls within the Historic Trend Line -Fairly Valued range.
0.25
PS
Jaguar Health Inc. (JAGX) has a current PS of 0.25. The 5-year average PS is 3.50. The thresholds are as follows: Strongly Undervalued below -8.99, Undervalued between -8.99 and -2.75, Fairly Valued between 9.75 and -2.75, Overvalued between 9.75 and 16.00, and Strongly Overvalued above 16.00. The current Forward PS of 0.25 falls within the Historic Trend Line -Fairly Valued range.
-0.29
P/OCF
Jaguar Health Inc. (JAGX) has a current P/OCF of -0.29. The 5-year average P/OCF is -1.65. The thresholds are as follows: Strongly Undervalued below -6.41, Undervalued between -6.41 and -4.03, Fairly Valued between 0.74 and -4.03, Overvalued between 0.74 and 3.12, and Strongly Overvalued above 3.12. The current Forward P/OCF of -0.29 falls within the Historic Trend Line -Fairly Valued range.
-0.90
P/FCF
Jaguar Health Inc. (JAGX) has a current P/FCF of -0.90. The 5-year average P/FCF is 3.91. The thresholds are as follows: Strongly Undervalued below -31.33, Undervalued between -31.33 and -13.71, Fairly Valued between 21.53 and -13.71, Overvalued between 21.53 and 39.14, and Strongly Overvalued above 39.14. The current Forward P/FCF of -0.90 falls within the Historic Trend Line -Fairly Valued range.
Jaguar Health Inc (JAGX) has a current Price-to-Book (P/B) ratio of 1.29. Compared to its 3-year average P/B ratio of 0.87 , the current P/B ratio is approximately 47.92% higher. Relative to its 5-year average P/B ratio of 3.22, the current P/B ratio is about -59.96% higher. Jaguar Health Inc (JAGX) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -433.72%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -289.00% , the current FCF yield is about -100.00% lower.
1.29
P/B
Median3y
0.87
Median5y
3.22
-624.02
FCF Yield
Median3y
-433.72
Median5y
-289.00
Competitors Valuation Multiple
The average P/S ratio for JAGX's competitors is 0.00, providing a benchmark for relative valuation. Jaguar Health Inc Corp (JAGX) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -0.80%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of JAGX decreased by 95.64% over the past 1 year. The primary factor behind the change was an decrease in Revenue Growth from 3.11M to 3.08M.
The secondary factor is the Margin Expansion, contributed -2.94%to the performance.
Overall, the performance of JAGX in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
FAQ
Is Jaguar Health Inc (JAGX) currently overvalued or undervalued?
What is Jaguar Health Inc (JAGX) fair value?
How does JAGX's valuation metrics compare to the industry average?
What is the current P/B ratio for Jaguar Health Inc (JAGX) as of Dec 05 2025?
What is the current FCF Yield for Jaguar Health Inc (JAGX) as of Dec 05 2025?
What is the current Forward P/E ratio for Jaguar Health Inc (JAGX) as of Dec 05 2025?